Skip to main content
Premium Trial:

Request an Annual Quote

Reprogen Names President, Closes $5.1 Million Financing Deal


IRVINE, Calif.--Functional genomics firm Reprogen named biophysicist and attorney Jeffrey Miller to the post of president and CEO. In previous positions as senior vice-president, corporate development, at Ostex Interna tion al for one year and at NeoRx for nine years, Miller negotiated strategic alliances with leading pharmaceuticals.

Reprogen also completed $5.1 million in private financing in February. Investors included UBS, Canadian venture fund Genechem, and current investors, Oxford Investors and BIMV, a Belgian venture fund. Reprogen uses functional genomics to identify molecular targets involved in reproductive diseases including endometriosis and ovarian, breast, and prostate cancers.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.